Music Licensing, Inc. (OTC: SONGD) Receives Third Royalty Payment from Stake in Listerine "Mouthwash" Antiseptic

Rhea-AI Summary

Music Licensing (OTC: SONGD) has announced the receipt of its third royalty payment from its stake in the Listerine 'Mouthwash' brand. This event highlights the company's successful diversification strategy within its investment portfolio. By leveraging its industry expertise and strategic foresight, Music Licensing has ensured a stable revenue stream that benefits its shareholders.

The consistent royalty payments from Listerine exemplify the company's commitment to generating reliable income through strategic investments. This marks a significant milestone for Music Licensing as it continues to innovate and diversify its revenue sources.

Positive

• Received third royalty payment from Listerine 'Mouthwash' investment.
• Successful diversification strategy benefiting shareholders.
• Consistent revenue stream from strategic investment.

Negative

• No specific financial data provided on the amount of the royalty payment.
• Dependence on external brands for revenue generation.
• Lack of information on future investment plans or expected revenue growth.

Naples, FL , May 20, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONGD) proudly announces the reception of its third royalty payment stemming from its stake in the iconic Listerine "Mouthwash" antiseptic brand. This achievement marks a significant milestone in the company's strategic investment portfolio.

As a pioneering player in the Music industry, Music Licensing, Inc. has consistently demonstrated its commitment to diversification and innovation. Leveraging its expertise and foresight, the company made a strategic investment in the Listerine "Mouthwash" antiseptic brand, recognizing its enduring appeal and market presence.

The receipt of this third royalty payment underscores the success of Music Licensing, Inc.'s investment strategy. Through prudent decision-making and proactive engagement, the company has secured a reliable revenue stream that adds value to its shareholders.

About Music Licensing, Inc. (OTC: SONGD)  (ProMusicRights.com)

Music Licensing, Inc. (OTC: SONG) a diversified holding company, also known as Pro Music Rights, is the 5th public performance rights organization (PRO) to be formed in the United States. Its licensees include notable companies such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others. Pro Music Rights holds an estimated market share of 7.4% in the United States, representing over 2,500,000 works that feature notable artists such as A$AP Rocky, Wiz Khalifa, Pharrell, Young Jeezy, Juelz Santana, Lil Yachty, MoneyBagg Yo, Larry June, Trae Pound, Sause Walka, Trae Tha Truth, Sosamann, Soulja Boy, Lex Luger, Trauma Tone, Lud Foe, SlowBucks, Gunplay, OG Maco, Rich The Kid, Fat Trel, Young Scooter, Nipsey Hussle, Famous Dex, Boosie Badazz, Shy Glizzy, 2 Chainz, Migos, Gucci Mane, Young Dolph, Trinidad James, Chingy, Lil Gnar, 3OhBlack, Curren$y, Fall Out Boy, Money Man, Dej Loaf, Lil Uzi Vert, and countless others, as well as Artificial Intelligence (A.I.) Created Music. Additionally, Music Licensing, Inc. (OTC: SONG) owns royalty stakes in Listerine "Mouthwash" Antiseptic as well as  musical works by artists such as Elton John, Lil Nas X, Miley Cyrus, Lil Wayne, XXXTentacion, Halsey, and numerous others.

Forward-Looking Statements:

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Music Licensing, Inc. & Pro Music Rights, Inc. to accomplish its stated plan of business. Music Licensing, Inc. & Pro Music Rights, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Pro Music Rights, Inc., Music Licensing, Inc., or any other person.

Non-Legal Advice Disclosure:

This press release does not constitute legal advice, and readers are advised to seek legal counsel for any legal matters or questions related to the content herein.

Non-Investment Advice Disclosure:

This communication is intended solely for informational purposes and does not in any way imply or constitute a recommendation or solicitation for the purchase or sale of any securities, commodities, bonds, options, derivatives, or any other investment products. Any decisions related to investments should be made after thorough research and consultation with a qualified financial advisor or professional. We assume no liability for any actions taken or not taken based on the information provided in this communication

Contact: investors@ProMusicRights.com

SOURCE: Music Licensing, Inc.

FAQ

What did Music Licensing (OTC: SONGD) announce regarding Listerine on May 20, 2024?

Music Licensing announced that it received its third royalty payment from its stake in the Listerine 'Mouthwash' brand.

How does the Listerine royalty payment benefit Music Licensing (OTC: SONGD) shareholders?

The consistent royalty payments from Listerine provide a reliable revenue stream, adding value to Music Licensing's shareholders.

What strategic move did Music Licensing (OTC: SONGD) make to secure revenue from Listerine?

Music Licensing made a strategic investment in the Listerine 'Mouthwash' brand, leveraging its industry expertise and foresight.

How many royalty payments has Music Licensing (OTC: SONGD) received from Listerine?

Music Licensing has received three royalty payments from its stake in the Listerine 'Mouthwash' brand.